VRN.TO Veren Inc. (TSX) Intraday 09 Feb 2026: Volume surge at C$9.14 suggests upside

VRN.TO stock is trading at C$9.14 intraday on the TSX after a 3.86% jump and a volume surge to 7,102,799 shares. We view today’s move as volume-driven interest in Veren Inc. (VRN.TO), tied to stronger year-to-date performance and cheaper valuation versus some peers. The stock’s average 50-day price is C$8.50 and the 200-day is C$8.23, which frames the current price near short-term resistance. For active traders, this most-active session shows higher liquidity and a clearer risk-reward profile

VRN.TO stock intraday snapshot and drivers

Trading on the TSX, Veren Inc. (VRN.TO) is at C$9.14 with a daily range C$8.86–C$9.21 and volume 7,102,799, above the average 5,566,824. This relative volume of 1.28x signals institutional or news-driven activity. Market chatter and comparisons in recent MarketBeat coverage may be feeding flows source. We link to competitor context on MarketBeat for sector positioning source.

VRN.TO stock fundamentals and valuation

Veren Inc. posts EPS 0.46 and a P/E of 19.87 on today’s price, with book value per share C$10.96 and a P/B of 0.83. Market cap is C$5.59B and enterprise value near C$8.64B, reflecting moderate leverage. Key ratios: ROE 6.29%, debt/equity 0.45, and free cash flow yield 5.23%. These metrics show value traits relative to the Energy sector average P/E 21.76, and a cheaper multiple.

VRN.TO stock technicals and trading signals

Technicals show an RSI at 100 (overbought) and ADX 50, indicating a strong trend but stretched momentum. Price sits above the 50-day (C$8.50) and 200-day (C$8.23) moving averages, which supports short-term bullish bias. Traders should watch intraday support C$8.86 and resistance C$9.21, plus volatility metric ATR C$0.33 for stop placement.

Meyka AI rates VRN.TO with a score out of 100 and model forecast

Meyka AI rates VRN.TO with a score out of 100 at 74.26/100, Grade B+ and suggestion BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a C$11.20 price target over 12 months, implying 22.54% upside versus the current C$9.14. Forecasts are model-based projections and not guarantees.

VRN.TO stock risks and opportunities

Opportunities: rising oil prices and strong N.A. production could lift margins; book value per share C$10.96 provides tangible asset support. Risks: capital spending reduced free cash flow growth and a current ratio 0.57 that signals working capital pressure. Also monitor net debt/EBITDA 2.36 and macro energy swings that drive volatility.

VRN.TO stock trading strategy and positioning

For most-active traders, use size-limited entries on pullbacks to C$8.85–C$8.50 with stops under C$8.40 and targets near C$10.50–C$11.20. Longer-term investors can assess valuation versus book value and a dividend yield near 1.26%. We recommend position sizing tied to sector exposure and liquidity, given daily volume above 7.10M.

Final Thoughts

Key takeaways for VRN.TO stock: intraday activity shows higher-than-average liquidity with price at C$9.14 and volume 7,102,799, marking it among the most active TSX names today. Fundamentals show a P/E 19.87, book value C$10.96, and a modest dividend yield 1.26%, while technicals point to a strong short-term trend (RSI 100, ADX 50). Meyka AI rates VRN.TO 74.26/100 (B+, BUY) and Meyka AI’s forecast model projects a C$11.20 target, implying ~22.54% upside versus today’s price. These numbers shape a balanced view: attractive relative valuation and clear upside, offset by working capital pressure and commodity risk. Use intraday liquidity and defined stops when trading. Meyka AI, our AI-powered market analysis platform, provides the grade and model output; forecasts are projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.